Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954092.793459874 ◽

2012 ◽

Author(s):

Joe Eron ◽

Christopher Hurt

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954092.793460468 ◽

2012 ◽

Author(s):

J Michael Kilby

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial

Clinical Infectious Diseases ◽

10.1093/cid/ciw395 ◽

2016 ◽

Vol 63 (6) ◽

pp. 818-820 ◽

Cited By ~ 6

Author(s):

Phanthaboon Wangpatharawanit ◽

Somnuek Sungkanuparph

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho

PLoS Medicine ◽

10.1371/journal.pmed.1003325 ◽

2020 ◽

Vol 17 (9) ◽

pp. e1003325

Author(s):

Alain Amstutz ◽

Bienvenu Lengo Nsakala ◽

Fiona Vanobberghen ◽

Josephine Muhairwe ◽

Tracy Renée Glass ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

First Line ◽

Open Label ◽

Low Level ◽

Randomized Controlled ◽

Hiv 1

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial

Antiviral Therapy ◽

10.3851/imp3171 ◽

2017 ◽

Vol 23 (1) ◽

pp. 21-32 ◽

Cited By ~ 1

Author(s):

Amanda H Yao ◽

◽

Cecilia L Moore ◽

Poh Lian Lim ◽

Jean-Michel Molina ◽

...

Keyword(s):

Controlled Trial ◽

Metabolic Profiles ◽

Second Line ◽

First Line ◽

Randomized Controlled ◽

First Line Therapy ◽

Line Therapy ◽

Hiv 1 ◽

Faculty Opinions recommendation of Initiating antiretroviral therapy for HIV at a patient's first clinic visit: the rapit randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726345532.793521455 ◽

2016 ◽

Author(s):

Marie-Louise Newell

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Clinic Visit ◽

Randomized Controlled

Randomized Controlled Trial: 4 Month versus 6 Month Monitoring of HIV-infected Patients on Highly Active Antiretroviral Therapy

Journal of Community Health ◽

10.1007/s10900-016-0188-4 ◽

2016 ◽

Vol 41 (5) ◽

pp. 1044-1048 ◽

Cited By ~ 2

Author(s):

Sharon Weissman ◽

Sarah Singh ◽

Shana Dykema ◽

R. David Parker

Keyword(s):

Antiretroviral Therapy ◽

Highly Active Antiretroviral Therapy ◽

Controlled Trial ◽

Randomized Controlled ◽

Highly Active

TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1392-3 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 2

Author(s):

Matthew B. Laurens ◽

Randy G. Mungwira ◽

Osward M. Nyirenda ◽

Titus H. Divala ◽

Maxwell Kanjala ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Open Label ◽

Randomized Controlled ◽

Open Label Trial

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

AIDS Research and Human Retroviruses ◽

10.1089/088922200414956 ◽

2000 ◽

Vol 16 (12) ◽

pp. 1113-1121 ◽

Cited By ~ 55

Author(s):

Andrew Wiznia ◽

Kenneth Stanley ◽

Paul Krogstad ◽

George Johnson ◽

Sophia Lee ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Controlled Trial ◽

Transcriptase Inhibitor ◽

Nucleoside Analog ◽

Randomized Controlled ◽

Reverse Transcriptase Inhibitor

The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa

PLoS Medicine ◽

10.1371/journal.pmed.1002808 ◽

2019 ◽

Vol 16 (5) ◽

pp. e1002808 ◽

Cited By ~ 7

Author(s):

Colleen F. Hanrahan ◽

Sheree R. Schwartz ◽

Mutsa Mudavanhu ◽

Nora S. West ◽

Lillian Mutunga ◽

...

Keyword(s):

South Africa ◽

Antiretroviral Therapy ◽

Viral Suppression ◽

Controlled Trial ◽

Pragmatic Randomized Controlled Trial ◽

Randomized Controlled ◽

The Impact